Ex Parte BREITNER et al - Page 5



                    Appeal No. 2003-0865                                                                    Page 5                       
                    Application No. 09/300,789                                                                                           

                            Regarding any putative evidence of prevention [of] the onset of                                              
                            Alzheimer’s disease, such cannot be forthcoming because there is                                             
                            no time limit for the onset of the disease.  That is, the disease can                                        
                            arise at any time after any experimentally designated time limit.                                            
                    Id., page 3.                                                                                                         
                            We reverse the examiner’s rejection.  First, we disagree with the                                            
                    examiner’s position that, since “the disease can arise at any time after any                                         
                    experimentally designated time limit,” preventing the symptoms of Alzheimer’s                                        
                    disease cannot be proven by experimental evidence.  We agree instead with                                            
                    Appellants that “a sufficient delay constitutes prevention.”  Appeal Brief, page 6.                                  
                    That is, if the symptoms of Alzheimer’s disease are delayed sufficiently that the                                    
                    individual dies before the symptoms manifest themselves, the symptoms of                                             
                    Alzheimer’s disease have been effectively prevented.                                                                 
                            In addition, even if the examiner’s interpretation was correct, the rejection                                
                    is improper for another reason:  the claims are not directed to a method of                                          
                    “preventing” the symptoms of Alzheimer’s disease; they are directed to a method                                      
                    of preventing or delaying the onset of those symptoms.  Thus, the claimed                                            
                    method is operative if it functions to either prevent or delay the onset of                                          
                    symptoms.  The examiner has not asserted that the claimed method does not                                            
                    function to delay the onset of Alzheimer’s disease symptoms.  Therefore, the                                         
                    method is not inoperative.  The rejection under 35 U.S.C. § 101 is reversed.                                         










Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007